DICUMAROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dicumarol, and when can generic versions of Dicumarol launch?
Dicumarol is a drug marketed by Lilly and Abbvie and is included in two NDAs.
The generic ingredient in DICUMAROL is dicumarol. There is one drug master file entry for this compound. Additional details are available on the dicumarol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DICUMAROL?
- What are the global sales for DICUMAROL?
- What is Average Wholesale Price for DICUMAROL?
Summary for DICUMAROL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Clinical Trials: | 1 |
| Patent Applications: | 5,566 |
| DailyMed Link: | DICUMAROL at DailyMed |
Recent Clinical Trials for DICUMAROL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Bologna | Phase 4 |
Medical Subject Heading (MeSH) Categories for DICUMAROL
US Patents and Regulatory Information for DICUMAROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | DICUMAROL | dicumarol | CAPSULE;ORAL | 005509-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | DICUMAROL | dicumarol | TABLET;ORAL | 005545-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lilly | DICUMAROL | dicumarol | CAPSULE;ORAL | 005509-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | DICUMAROL | dicumarol | TABLET;ORAL | 005545-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbvie | DICUMAROL | dicumarol | TABLET;ORAL | 005545-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
